239 related articles for article (PubMed ID: 30987694)
1. Cis-2-dodecenoic Acid Mediates Its Synergistic Effect with Triazoles by Interfering with Efflux Pumps in Fluconazole-resistant Candida albicans.
Yang DL; Hu YL; Yin ZX; Zeng GS; Li D; Zhang YQ; Xu ZH; Guan XM; Weng LX; Wang LH
Biomed Environ Sci; 2019 Mar; 32(3):199-209. PubMed ID: 30987694
[TBL] [Abstract][Full Text] [Related]
2. Upc2-mediated mechanisms of azole resistance in
Li J; Aubry L; Brandalise D; Coste AT; Sanglard D; Lamoth F
Microbiol Spectr; 2024 Feb; 12(2):e0352623. PubMed ID: 38206035
[No Abstract] [Full Text] [Related]
3. Deciphering azole resistance mechanisms with a focus on transcription factor-encoding genes TAC1, MRR1 and UPC2 in a set of fluconazole-resistant clinical isolates of Candida albicans.
Morio F; Pagniez F; Besse M; Gay-andrieu F; Miegeville M; Le Pape P
Int J Antimicrob Agents; 2013 Nov; 42(5):410-5. PubMed ID: 24051054
[TBL] [Abstract][Full Text] [Related]
4.
Nishimoto AT; Wiederhold NP; Flowers SA; Zhang Q; Kelly SL; Morschhäuser J; Yates CM; Hoekstra WJ; Schotzinger RJ; Garvey EP; Rogers PD
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910896
[TBL] [Abstract][Full Text] [Related]
5. Expression of Major Efflux Pumps in Fluconazole-Resistant Candida albicans.
Pourakbari B; Teymuri M; Mahmoudi S; Valian SK; Movahedi Z; Eshaghi H; Mamishi S
Infect Disord Drug Targets; 2017; 17(3):178-184. PubMed ID: 28558643
[TBL] [Abstract][Full Text] [Related]
6. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Sanglard D; Coste AT
Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
[TBL] [Abstract][Full Text] [Related]
7. [Investigation of mutations in transcription factors of efflux pump genes in fluconazole-resistant Candida albicans strains overexpressing the efflux pumps].
Kalkandelen KT; Doluca Dereli M
Mikrobiyol Bul; 2015 Oct; 49(4):609-18. PubMed ID: 26649419
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of resistance to fluconazole in Candida albicans clinical isolates from Iranian HIV-infected patients with oropharyngeal candidiasis.
Salari S; Khosravi AR; Mousavi SA; Nikbakht-Brojeni GH
J Mycol Med; 2016 Mar; 26(1):35-41. PubMed ID: 26627124
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India.
Mane A; Vidhate P; Kusro C; Waman V; Saxena V; Kulkarni-Kale U; Risbud A
Mycoses; 2016 Feb; 59(2):93-100. PubMed ID: 26648048
[TBL] [Abstract][Full Text] [Related]
10. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
Oz Y; Akşit F; Kiraz N; Kiremitçi A
Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
[TBL] [Abstract][Full Text] [Related]
11. The anti-staphylococcal fusidic acid as an efflux pump inhibitor combined with fluconazole against vaginal candidiasis in mouse model.
Gomaa SE; Abbas HA; Mohamed FA; Ali MAM; Ibrahim TM; Abdel Halim AS; Alghamdi MA; Mansour B; Chaudhary AA; Elkelish A; Boufahja F; Hegazy WAH; Yehia FAA
BMC Microbiol; 2024 Feb; 24(1):54. PubMed ID: 38341568
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of azole resistance in Candida albicans clinical isolates from Shanghai, China.
Liu JY; Shi C; Wang Y; Li WJ; Zhao Y; Xiang MJ
Res Microbiol; 2015 Apr; 166(3):153-61. PubMed ID: 25748216
[TBL] [Abstract][Full Text] [Related]
13. Induction of Candida albicans drug resistance genes by hybrid zinc cluster transcription factors.
Schneider S; Morschhäuser J
Antimicrob Agents Chemother; 2015 Jan; 59(1):558-69. PubMed ID: 25385116
[TBL] [Abstract][Full Text] [Related]
14. Eucalyptal D Enhances the Antifungal Effect of Fluconazole on Fluconazole-Resistant
Xu J; Liu R; Sun F; An L; Shang Z; Kong L; Yang M
Front Cell Infect Microbiol; 2019; 9():211. PubMed ID: 31281800
[TBL] [Abstract][Full Text] [Related]
15. Azole resistance in Candida albicans from animals: Highlights on efflux pump activity and gene overexpression.
Rocha MFG; Bandeira SP; de Alencar LP; Melo LM; Sales JA; Paiva MAN; Teixeira CEC; Castelo-Branco DSCM; Pereira-Neto WA; Cordeiro RA; Sidrim JJC; Brilhante RSN
Mycoses; 2017 Jul; 60(7):462-468. PubMed ID: 28295690
[TBL] [Abstract][Full Text] [Related]
16. Blocking of Candida albicans biofilm formation by cis-2-dodecenoic acid and trans-2-dodecenoic acid.
Zhang Y; Cai C; Yang Y; Weng L; Wang L
J Med Microbiol; 2011 Nov; 60(Pt 11):1643-1650. PubMed ID: 21778264
[TBL] [Abstract][Full Text] [Related]
17. Drug resistance genes and trailing growth in Candida albicans isolates.
Lee MK; Williams LE; Warnock DW; Arthington-Skaggs BA
J Antimicrob Chemother; 2004 Feb; 53(2):217-24. PubMed ID: 14688046
[TBL] [Abstract][Full Text] [Related]
18. Synergistic and drug-resistant reversing effects of diorcinol D combined with fluconazole against Candida albicans.
Li Y; Chang W; Zhang M; Li X; Jiao Y; Lou H
FEMS Yeast Res; 2015 Mar; 15(2):. PubMed ID: 25752309
[TBL] [Abstract][Full Text] [Related]
19. Strong synergism of dexamethasone in combination with fluconazole against resistant Candida albicans mediated by inhibiting drug efflux and reducing virulence.
Sun W; Wang D; Yu C; Huang X; Li X; Sun S
Int J Antimicrob Agents; 2017 Sep; 50(3):399-405. PubMed ID: 28673609
[TBL] [Abstract][Full Text] [Related]
20. Interactions of a prenylated flavonoid from Dalea elegans with fluconazole against azole- resistant Candida albicans.
Barceló S; Peralta M; Calise M; Finck S; Ortega G; Diez RA; Cabrera JL; Pérez C
Phytomedicine; 2017 Aug; 32():24-29. PubMed ID: 28732804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]